Literature DB >> 3450849

The use of Weibull distribution to describe the in vivo absorption kinetics.

V K Piotrovskii1.   

Abstract

The drug in vivo absorption rate reflects the distribution of drug molecules absorption times. For the latter the Weibull distribution is suggested and some examples taken from the literature are used to support the proposal. Cumulative absorption data for theophylline in man and pantothenic acid in rats are linearized in the double log coordinates, and the Weibull absorption model parameters are estimated by linear regression. The mean absorption time values calculated from these parameters are in close agreement with those assessed by the model-independent method.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3450849     DOI: 10.1007/BF01068420

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

1.  Theory of the mean absorption time, an adjunct to conventional bioavailability studies.

Authors:  D J Cutler
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

2.  Pharmacokinetic stochastic model with Weibull-distributed residence times of drug molecules in the body.

Authors:  V K Piotrovskii
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Estimation of drug absorption rates using a deconvolution method with nonequal sampling times.

Authors:  K Iga; Y Ogawa; T Yashiki; T Shimamoto
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

4.  Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.

Authors:  A A Firsov; V K Piotrovskii
Journal:  Pharmazie       Date:  1986-06       Impact factor: 1.267

5.  Physical interpretation of parameters in the Rosin-Rammler-Sperling-Weibull distribution for drug release from controlled release dosage forms.

Authors:  F N Christensen; F Y Hansen; H Bechgaard
Journal:  J Pharm Pharmacol       Date:  1980-08       Impact factor: 3.765

6.  Moment analysis in vivo and in vitro.

Authors:  H M von Hattingberg
Journal:  Methods Find Exp Clin Pharmacol       Date:  1984-10

7.  Mathematical basis of point-area deconvolution method for determining in vivo input functions.

Authors:  D P Vaughan; M Dennis
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

8.  Linearization of dissolution rate curves by the Weibull distribution.

Authors:  F Langenbucher
Journal:  J Pharm Pharmacol       Date:  1972-12       Impact factor: 3.765

9.  New compartment- and model-independent method for rapid calculation of drug absorption rates.

Authors:  W L Chiou
Journal:  J Pharm Sci       Date:  1980-01       Impact factor: 3.534

  9 in total
  13 in total

1.  Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5-HT4 receptor agonist, following oral and intravenous administration.

Authors:  S Appel-Dingemanse; M O Lemarechal; A Kumle; M Hubert; E Legangneux
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

2.  Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.

Authors:  Matthew W Linakis; Joseph E Rower; Jessica K Roberts; Eleanor I Miller; Diana G Wilkins; Catherine M T Sherwin
Journal:  Br J Clin Pharmacol       Date:  2017-09-06       Impact factor: 4.335

3.  A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patients.

Authors:  L Evans; L Aarons; P Coates
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

4.  Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjects.

Authors:  Alexander K Berg; Sumithra J Mandrekar; Katie L Allen Ziegler; Elsa C Carlson; Eva Szabo; Mathew M Ames; Daniel Boring; Paul J Limburg; Joel M Reid
Journal:  J Clin Pharmacol       Date:  2013-02-22       Impact factor: 3.126

5.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

6.  Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.

Authors:  Maria C Kjellsson; Laura E Via; Anne Goh; Danielle Weiner; Kang Min Low; Steven Kern; Goonaseelan Pillai; Clifton E Barry; Véronique Dartois
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

7.  Application of the convection-dispersion equation to modelling oral drug absorption.

Authors:  Jan I Freijer; Teun M Post; Bart A Ploeger; Joost DeJongh; Meindert Danhof
Journal:  Bull Math Biol       Date:  2006-10-06       Impact factor: 1.758

8.  Population pharmacokinetic analysis of lanreotide Autogel in healthy subjects : evidence for injection interval of up to 2 months.

Authors:  Iñaki F Trocóniz; Josep-María Cendrós; Concepción Peraire; Joaquim Ramis; Maria J Garrido; Paolo F Boscani; Rosendo Obach
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

9.  Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency.

Authors:  M Galtier; F Bressolle; J E de la Coussaye; R Gomeni; P Joubert; F Gény; A Dubois; C Raffanel; G Saissi; J J Eledjam
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

10.  Modeling of the saturable time-constrained amoxicillin absorption in humans.

Authors:  V K Piotrovskij; G Paintaud; G Alván; T Trnovec
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.